ArticleBMC cancer2016
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer.
Marc A Becker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleBMC cancer2016
Marc A Becker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.